{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":29,"n_cols":5,"rows_kept":29,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[15,2,15,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[23,2,23,3],[24,2,24,3],[28,2,28,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISANNIOTO00556585"]
[null,null,"Autore",null,"D'Alessandro, Floriano"]
[null,null,"Titolo",null,"Scritti di Floriano d'Alessandro"]
[null,null,"Pubbl/distr/stampa",null,"Milano, : Giuffrè, 1997"]
[null,null,"ISBN",null,"8814055157"]
[null,null,"Descrizione fisica",null,"2 v. ;24 cm"]
[null,null,"Collana",null,"Pubblicazioni dell'Istituto di diritto privato / Università degli studi di Roma La Sapienza, Facoltà di economia e commercio \\poi! Università degli studi di Roma La Sapienza, Facoltà di economia ; 11"]
[null,null,"Collocazione",null,"D         (AR) 21                 88801D         (AR) 21                 889"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Già pubbl."]
[null,"2.","Record Nr.",null,"UNINA9910974219603321"]
[null,null,"Titolo",null,"Challenges for the FDA : the future of drug safety : workshop summary / / Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs"]
[null,null,"Pubbl/distr/stampa",null,"Washington, DC, : National Academies Press, c2007"]
[null,null,"ISBN",null,"0-309-17944-0"]
[{"$nulls":4},"1-281-09355-6"]
[{"$nulls":4},"9786611093556"]
[{"$nulls":4},"0-309-10987-6"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"xvii, 109 p. : ill"]
[null,null,"Soggetti",null,"Drugs - United States - Testing"]
[{"$nulls":4},"Drugs - United States - Safety measures"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 78-79)."]
[null,null,"Nota di contenuto",null,"FrontMatter -- Reviewers -- Preface -- Contents -- Tables, Figures, and Boxes -- Summary -- 1 Introduction -- 2 Addressing the FDA's Resource Challenges -- 3 Strengthening the Scientific Base of the Agency -- 4 Integrating Pre- and Postmarket Review -- 5 Enhancing Postmarket Safety Monitoring -- 6 Conducting Confirmatory Drug Safety and Efficacy Studies -- 7 Enhancing the Value of Clinical Trial Registration -- 8 Enhancing Postmarket Regulation and Enforcement -- 9 Looking to the Future -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Speaker Biographies."]